Baycan Omer Faruk, Fidan Serdar, Celik Fatma Betul, Tatlisu Mustafa Adem, Ozyildirim Serhan, Caliskan Mustafa
Istanbul Medeniyet University Faculty of Medicine; Istanbul Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Department of Cardiology, Istanbul, Turkey.
Kartal Kosuyolu Heart Training and Research Hospital, Clinic of Cardiology, Istanbul, Turkey.
Medeni Med J. 2023 Mar 28;38(1):32-38. doi: 10.4274/MMJ.galenos.2023.00532.
Premature ventricular contractions (PVCs) are a common arrhythmic condition. The first approach in patients with symptomatic and frequent PVC is medical treatment, primarily beta-blockers (BB) or calcium channel blockers (CCB), but it is still unclear which of the two should be chosen. This study investigated which drug treatment would be beneficial according to patient and electrocardiography (ECG) characteristics in patients with idiopathic PVC.
We retrospectively analyzed 156 patients with PVC who came to the cardiology outpatient clinic. Seventy-one patients were responsive to BB, and 85 were responsive to CCB. Their demographic and ECG characteristics were compared.
The male ratio was higher (p<0.001), and the left ventricular ejection fraction was lower in BB responders than in CCB responders (p<0.001). Although the mean heart rate was higher in BB responders (p<0.001), the initial PVC burden was lower in BB responders than in CCB responders (p<0.001). The PVC QRS duration was longer in BB responders than in CCB responders (p<0.001). Similarly, the coupling interval variability was higher in BB responders (p=0.006).
The evaluation of clinical and ECG parameters in patients with frequent idiopathic PVCs may determine whether BBs or CCBs should be chosen as initial treatment. Further prospective studies are needed to verify our findings and establish their clinical applicability.
室性早搏(PVCs)是一种常见的心律失常疾病。对于有症状且频发PVCs的患者,首要治疗方法是药物治疗,主要是β受体阻滞剂(BB)或钙通道阻滞剂(CCB),但仍不清楚应选择两者中的哪一种。本研究调查了根据特发性PVCs患者的临床特征和心电图(ECG)特征,哪种药物治疗更有益。
我们回顾性分析了156例到心脏病门诊就诊的PVCs患者。71例患者对BB有反应,85例对CCB有反应。比较了他们的人口统计学和心电图特征。
BB反应者的男性比例更高(p<0.001),左心室射血分数低于CCB反应者(p<0.001)。虽然BB反应者的平均心率更高(p<0.001),但BB反应者的初始PVC负荷低于CCB反应者(p<0.001)。BB反应者的PVC QRS时限比CCB反应者更长(p<0.001)。同样,BB反应者的联律间期变异性更高(p=0.006)。
对频发特发性PVCs患者的临床和心电图参数进行评估,可能有助于确定应选择BB还是CCB作为初始治疗药物。需要进一步的前瞻性研究来验证我们的发现并确定其临床适用性。